A Drug-Resistant Superbug May Be Stealthily Spreading

Person-to-person transmission of carbapenem-resistant Enterobacteriaceae in US hospitals may be occurring without symptoms, a new study suggests.

Written byDiana Kwon
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

CRE (right) can grow in the presence of antibiotics CDC

The drug-resistant carbapenem-resistant Enterobacteriaceae (CRE) may be capable of spreading in more ways—and more insidiously—than previously thought, according to a study published January 16 in PNAS. CREs are resistant to multiple antibiotics including last-resort drugs like carbapenem, and have been called “nightmare” bacteria by Tom Frieden, director of the Centers for Disease Control and Prevention.

Researchers at the Broad Institute of MIT and Harvard analyzed 250 CRE samples from patients across four US hospitals, three in Boston and one in California. They found that the bacteria not only displayed remarkable genetic diversity and a variety of carbapenem resistance genes, but they were able to transfer resistance genes between species.

Although the researchers were unable to find much evidence of person-to-person transmission, CREs may be spreading ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Diana is a freelance science journalist who covers the life sciences, health, and academic life. She’s a regular contributor to The Scientist and her work has appeared in several other publications, including Scientific American, Knowable, and Quanta. Diana was a former intern at The Scientist and she holds a master’s degree in neuroscience from McGill University. She’s currently based in Berlin, Germany.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies